4th Quarter - Report

JAMES EDWARDS for CONSERVATIVES FOR PROPERTY RIGHTS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 2082/H.R. 3666 (STRONGER Patents Act) Trade-related intellectual property policy/practices/encroachment by foreign countries/companies against U.S. competitiveness interests - China, Committee on Foreign Investment in the United States review of Chinese acquisitions and joint ventures, United States-Mexico-Canada Agreement IP chapter, International Trade Commission exclusion of U.S. patent-infringing imports, ITC baseband chip set patent infringement remedy, intellectual property exclusivity and protections in trade agreements Piracy of online and streaming copyrighted content Compulsory licensing - S. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act), S. 102/H.R. 465 (Prescription Drug Price Relief Act), S. 977 (Transparent Drug Pricing Act) NIST Return on Investment Initiative for Unleashing American Innovation S. 344/H.R. 990 (Hatch-Waxman Integrity Act) FTC/patent licensing as exclusive property right Bayh-Dole Act/technology transfer, misuse of march-in rights Procedural and evidentiary standards used at Patent Trial and Appeal Board PTO patentable subject matter eligibility guidance Section 101 patentable subject matter reform Injunctive relief from willful infringement DOJ-DOC withdrawal of 2013 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments S. 1273/H.R. 2426 (Copyright Alternative in Small-Claims Enforcement (CASE) Act) S. 1416 (Affordable Prescriptions for Patients Act) Obviousness/No Combination Drug Patents Act H.R. 4398/H.R. 5133 (Affordable Prescriptions for Patients Through Promoting Competition Act) H.R. 3991 (Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act) H.R. 5478 (Inventor Rights Act) Patent licensing/standards-essential patents/U.S. technological leadership in 5G and other technologies/economic and national security implications DOJ-PTO-NIST 2019 revised Joint Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments Efficient infringement Digital Millennium Copyright Act modernization Patent Trial & Appeal Board Covered Business Methods program PTAB Rules of Practice for Instituting on All Challenged Patent Claims and All Grounds and Eliminating the Presumption at Institution Favoring Petitioner as to Testimonial Evidence (Docket No. PTO-P-2019-0024) S. 3630 (Facilitating Innovation to Fight Coronavirus Act) Denial of rights of exclusivity for COVID-19-related innovations H.R. 7366 (Restoring Americas Leadership in Innovation Act) S. 3835 (SCRIPT Act) Proposed policy requiring privately produced, privately funded, copyrighted, peer-reviewed journal articles be given away free upon publication if they discuss any underlying research supported by a government grant Patent Trial and Appeal Board Covered Business Methods program statutory expiration Appointments Clause and the constitutionality of AdministrativePatent Judges invalidation of patents Amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board (RIN:0651-AD47) Discretion to Institute Trials Before the Patent Trial and Appeal Board (Docket No. PTO-C-2020-0055) H.R. 133 (Consolidated Appropriations Act FY 2021 provisions related to Patent & Trademark Office, CASE Act, and copyright infringement via streaming loophole reform)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO)

Bills named: S. 977 (116th), H.R. 3666 (116th), H.R. 133 (116th), S. 344 (116th), H.R. 990 (116th), S. 3630 (116th), S. 2082 (116th), H.R. 7366 (116th), H.R. 5133 (116th), H.R. 4398 (116th), S. 3835 (116th), H.R. 465 (116th), H.R. 2426 (116th), H.R. 3991 (116th), H.R. 1046 (116th), S. 102 (116th), S. 1416 (116th), H.R. 5478 (116th), S. 377 (116th), S. 1273 (116th)

Taxation/Internal Revenue Code TAX

S. 215/H.R. 218 (Death Tax Repeal Act) H.R. 3301 (Taxpayer Certainty and Disaster Tax Relief Act) Wealth tax Treasury Dept. Estate and Gift Taxes Regulation re Difference in the Basic Exclusion Amount H.R. 5377 (Restoring Tax Fairness for States and Localities Act) SALT deductibility cap repeal H.R. 6690 (BEAT CHINA Act) tax incentives to relocate factories to U.S.

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 6690 (116th), H.R. 5377 (116th), S. 215 (116th), H.R. 218 (116th), H.R. 3301 (116th)

Medicare/Medicaid MMM

Proposed International Pricing Index (IPI) payment model for drugs administered under Medicare Part B S. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act) Reform of drug manufacturer rebates to third parties (e.g., pharmaceutical benefits managers, insurers) Proposed binding arbitration for enacting government price controls under Medicare Part D Inflationary penalty as government price controls in Medicare Part D/S. 2543 (Prescription Drug Pricing Reduction Act) S. 1129/H.R. 1384 (Medicare for All Act) Single-payer health care Government price controls on health care products, services, providers, payers H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act) drug price controls through international reference pricing, direct federal price dictation, confiscatory penalty on the most innovative medicines Importation of Prescription Drugs Proposed Rule (Docket No. FDA-2019-N-5711) H.R. 1425 (Patient Protection and Affordable Care Enhancement Act) H.R. 6674 (Medicare Crisis Program Act) Proposed most favored nation government price controls for pharmaceuticals Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements (Docket No. CMS-2482-P) Interim Final Rule, Most Favored Nation (MFN) Model (Docket No. CMS-5528-IFC)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Bills named: H.R. 6674 (116th), S. 377 (116th), H.R. 1384 (116th), H.R. 1425 (116th), S. 2543 (116th), H.R. 3 (116th), H.R. 1046 (116th), S. 1129 (116th)

Real Estate/Land Use/Conservation RES

Waters of the United States rule repeal - by regulatory reform of WOTUS, in appropriations S.Res. 59/H.Res. 109 (Green New Deal resolution calling for the socialistic federal takeover of private property of American citizens and organizations and extinction of any meaningful private property rights in the United States) Land management/acquisition Public access to federally owned lands for sports, recreation, mining, commercial use Social Costs of Carbon project termination EPA regulatory and permitting reform Draft Environmental Impact Statement for the Pebble Mine Project H.R. 1373 (Grand Canyon Centennial Protection Act) H.R. 2181 (Chaco Cultural Heritage Area Protection Act) H.R. 3405 (Uranium Classification Act) Methane Rule reform Regulatory fairness and due process/National Environmental Policy Act reform (Docket No. CEQ-2019-0003-0001) Navigable Waters Protection Rule definition of waters of the United States (Docket No. EPA-HQ-OW-2018-0149, FRL-10004-88-OW) H.R. 7061 (American Critical Mineral Exploration and Innovation Act) S. 3422 (Great American Outdoors Act)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Executive Office of the President (EOP)

Bills named: H.R. 7061 (116th), H.R. 1373 (116th), H.R. 3405 (116th), H.Res. 109 (116th), H.R. 2181 (116th), S. 3422 (116th), S.Res. 59 (116th)

Small Business SMB

H.R. 6395 (National Defense Authorization Act, FY 2021, "Corporate Transparency Act" provision imposing a heavy regulatory burden on small businesses)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6395 (116th)

Telecommunications TEC

Department of Defense Request for Information on a government-run process for 5G development regarding Dynamic Spectrum Sharing (DSS) Nationalization of 5G wireless telecommunications

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Trade (domestic/foreign) TRD

H.R. 8037 (legislation to unbalance the U.S. International Trade Commissions standards in Tariff Act Section 337 cases involving U.S. businesses seeking relief against foreign-made, patent-infringing imports)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Bills named: H.R. 8037 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.